LifeSci Acquisition Corporation (NASDAQ:LSAC) announced in an 8-K that its shareholders approved its combination with cancer drug developer Vincera Pharma at a special meeting earlier today.
The parties expect the transaction to close tomorrow, December 23. The filing did not divulge redemption figures, but LifeSci opened the morning of the vote at $19, so one would guess they were “manageable”.
All measures up for a vote passed by wide margins, but about 12.5% of shares voted against the combined company’s incentive plan.
LifeSci initially announced its combination with with Vincera September 29. Vincera is developing a preclinical bioconjugation platform targeting surface markers for solid tumors.
For a full list of measures on the ballot as well as vote tallies, click HERE.
At the SPAC of Dawn Happy Friday! SPACInsider has unveiled new presets on SPAC Performance accessible via the Data drop-down to easily sort for the highest and lowest performing active SPACs and de-SPACs. On the de-SPAC side, Vertiv (NYSE:VRT) continues to be well ahead of the pack, logging a 710% return by share price adjusted...
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...